Evolution of Clinical Pharmacy in the USA and Future Directions for Patient Care

Drugs and Aging

Volumn 33, Issue 3, 2016, Pages 169-177

  Carter, Barry L ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMBULATORY CARE; CLINICAL PHARMACY; EVOLUTION; HOSPITAL CARE; HUMAN; MEDICAL PRACTICE; PATIENT CARE; PHARMACIST; PRIORITY JOURNAL; RESIDENCY EDUCATION; REVIEW; UNITED STATES; CERTIFICATION; HOSPITAL PHARMACY; TRENDS;

CERTIFICATION; HUMANS; PATIENT CARE; PHARMACISTS; PHARMACY SERVICE, HOSPITAL;

EID: 84962168878     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-016-0349-2     Document Type: Review

References (71)

1. McLeod DC, Miller WA. The practice of pharmacy: institutional and ambulatory pharmaceutical services. Cincinnati: Harvey Whitney Books; 1981.
2. Elenbaas RM, Worthen DB. Clinical pharmacy in the United States: transformation of a profession. Lenexa: American College of Clinical Pharmacy; 2009.
3. Buttaro M. AACP house of delegates vote: colleges to move to sole entry-level Pharm.D. Am J Hosp Pharm. 1992;49:2346–50.
4. American Council for Pharmacy Education. Standards revision 2016. https://www.acpe-accredit.org/deans/StandardsRevision.asp. Accessed 16 Dec 2015.
5. McLeod DC. Pharmacy residency and fellowship training programs. In: McLeod DC, Miller WA, editors. The practice of pharmacy: institutional and ambulatory pharmaceutical services. Cincinnati: Harvey Whitney Books; 1981. p. 482–97.
6. Cardoni AA, Jackson EA. Drug information services. In: McLeod DC, Miller WA, editors. The practice of pharmacy: institutional and ambulatory pharmaceutical services. Cincinnati: Harvey Whitney Books; 1981. p. 94–113.
7. Black HJ, Tester WW. Pharmacy operation utilizing unit dose concept. Am J Hosp Pharm. 1964;21:343–50.
8. Smith WE, de Leon RF, Herfindal ET, Hirschmann JL, Miller RA. The Ninth-Floor Pharmacy Project at the University of California, San Francisco: a seminal development in clinical pharmacy. Am J Health Syst Pharm. 2015;72:2108–13.
9. Carter BL, Elliott WJ. The role of pharmacists in the detection, management, and control of hypertension: a national call to action. Pharmacotherapy. 2000;20:119–22.
10. Carter BL, Helling DK. Ambulatory care pharmacy services: the incomplete agenda. Ann Pharmacother. 1992;26:701–8.
11. Carter BL, Helling DK. Ambulatory care pharmacy services: has the agenda changed? Ann Pharmacother. 2000;34:772–87.
12. Love DW, McWhinney BD. Ambulatory clinical practice programs. In: McLeod DC, Miller WA, editors. The practice of pharmacy: institutional and ambulatory pharmaceutical services. Cincinnati: Harvey Whitney Books; 1981. p. 202–15.
13. Carter BL, Helling DK, Jones ME, Moessner H, Waterbury CA Jr. Evaluation of family physician prescribing: influence of the clinical pharmacist. Drug Intell Clin Pharm. 1984;18:817–21.
14. McKenney JM, Slining JM, Henderson HR, Devins D, Barr M. The effect of clinical pharmacy services on patients with essential hypertension. Circulation. 1973;48:1104–11.
15. Monson R, Bond CA, Schuna A. Role of the clinical pharmacist in improving drug therapy: clinical pharmacists in outpatient therapy. Arch Intern Med. 1981;141:1441–4.
16. Juhl RP, Perry PJ, Norwood GJ, Martin LR. The family practitioner-clinical pharmacist group practice: a model clinic. Drug Intell Clin Pharm. 1974;8:572–5.
17. Perry PJ, Hurley SC. Activities of the clinical pharmacist practicing in the office of a family practitioner. Drug Intell Clin Pharm. 1975;9:129–33.
18. Helling DK, Hepler CD, Jones ME. Effect of direct clinical pharmaceutical services on patients’ perceptions of health care quality. Am J Hosp Pharm. 1979;36:325–9.
19. Helling DK. Family practice pharmacy service: part I. Drug Intell Clin Pharm. 1981;15:971–7.
20. Helling DK. Family practice pharmacy service: part II. Drug Intell Clin Pharm. 1982;16:35–48.
21. Reinders TP, Steinke WE. Pharmacist management of anticoagulant therapy in ambulant patients. Am J Hosp Pharm. 1979;36:645–8.
22. McKenney JM, Witherspoon JM, Pierpaoli PG. Initial experiences with a pharmacy clinic in a hospital-based group medical practice. Am J Hosp Pharm. 1981;38:1154–8.
23. Scrivens JJ Jr, Magalian P, Crozier GA. Cost-effective clinical pharmacy services in a veterans administration drop-in clinic. Am J Hosp Pharm. 1983;40:1952–3.
24. Directions for clinical practice in pharmacy. Proceedings of an invitational conference conducted by the ASHP Research and Education Foundation and the American Society of Hospital Pharmacists. February 10–13, 1985. Am J Hosp Pharm. 1985;42:1287–1292.
25. Acquisto NM, Hays DP. Emergency medicine pharmacy: still a new clinical frontier. Am J Health Syst Pharm. 2015;72:2092–6.
26. Shank BR, Schwartz RN, Fortner C, Finley RS. Advances in oncology pharmacy practice. Am J Health Syst Pharm. 2015;72:2098–100.
27. Carmichael JM, Hall DL. Evolution of ambulatory care pharmacy practice in the past 50 years. Am J Health Syst Pharm. 2015;72:2087–91.
28. Benedict N, Hess MM. History and future of critical care pharmacy practice. Am J Health Syst Pharm. 2015;72:2101–5.
29. Hepler CD. Unresolved issues in the future of pharmacy. Am J Hosp Pharm. 1988;45:1071–81.
30. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.
31. Levy G, Tsuchiya T. Salicylate accumulation kinetics in man. N Engl J Med. 1972;287:430–2.
32. DeVane CL. Parents and mentors may be gone but they are never forgotten. Pharmacotherapy. 2015;35:1–3.
33. Jelliffe RW, Brooker G. A nomogram for digoxin therapy. Am J Med. 1974;57:63–8.
34. Hull JH, Sarubbi FA Jr. Gentamicin serum concentrations: pharmacokinetic predictions. Ann Intern Med. 1976;85:183–9.
35. Carter BL, Bosworth HB, Green BB. The hypertension team: the role of the pharmacist, nurse, and teamwork in hypertension therapy. J Clin Hypertens (Greenwich). 2012;14:51–65.
36. Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169:1996–2002.
37. Borenstein JE, Graber G, Saltiel E, et al. Physician-pharmacist comanagement of hypertension: a randomized, comparative trial. Pharmacotherapy. 2003;23:209–16.
38. Chisholm-Burns MA, Kim Lee J, Spivey CA, et al. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010;48:923–33.
39. Hammond RW, Schwartz AH, Campbell MJ, et al. Collaborative drug therapy management by pharmacists: 2003. Pharmacotherapy. 2003;23:1210–25.
40. Malone DC, Carter BL, Billups SJ, et al. An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: the IMPROVE study: Impact of Managed Pharmaceutical Care Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy. 2000;20:1149–58.
41. Carter BL, Coffey CS, Ardery G, et al. Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2015;8:235–43.
42. Carter BL, Bergus GR, Dawson JD, et al. A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. J Clin Hypertens (Greenwich). 2008;10:260–71.
43. Carter BL, Foppe van Mil JW. Comparative effectiveness research: evaluating pharmacist interventions and strategies to improve medication adherence. Am J Hypertens. 2010;23:949–955.
44. Carter BL. Designing quality health services research: why comparative effectiveness studies are needed and why pharmacists should be involved. Pharmacotherapy. 2010;30:751–7.
45. Weber CA, Ernst ME, Sezate GS, Zheng S, Carter BL. Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Arch Intern Med. 2010;170:1634–9.
46. Chen Z, Ernst ME, Ardery G, Xu Y, Carter BL. Physician-pharmacist co-management and 24-hour blood pressure control. J Clin Hypertens (Greenwich). 2013;15:337–43.
47. Von Muenster SJ, Carter BL, Weber CA, et al. Description of pharmacist interventions during physician-pharmacist co-management of hypertension. Pharm World Sci. 2008;30:128–35.
48. Svarstad BL, Kotchen JM, Shireman TI, et al. Improving refill adherence and hypertension control in black patients: Wisconsin TEAM trial. J Am Pharm Assoc. 2013;53:520–9.
49. Carter BL, Clarke W, Ardery G, et al. A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2010;3:418–23.
50. Carter BL, Coffey CS, Uribe L, et al. Similar blood pressure values across racial and economic groups: baseline data from a group randomized clinical trial. J Clin Hypertens (Greenwich). 2013;15:404–12.
51. Dickerson LM, Kraus C, Kuo GM, et al. Formation of a primary care pharmacist practice-based research network. Am J Health Syst Pharm. 2007;64:2044–9.
52. Maddux MS. Board of Regents commentary. Qualifications of pharmacists who provide direct patient care: perspectives on the need for residency training and board certification. Pharmacotherapy. 2013;33:888–91.
53. Council on Credentialing in Pharmacy. Scope of contemporary pharmacy practice: roles, responsibilities, and functions of pharmacists and pharmacy technicians. http://www.pharmacycredentialing.org/Contemporary_Pharmacy_Practice.pdf. Accessed 2 April 2014.
54. Murphy JE, Nappi JM, Bosso JA, et al. American College of Clinical Pharmacy’s vision of the future: postgraduate pharmacy residency training as a prerequisite for direct patient care practice. Pharmacotherapy. 2006;26:722–33.
55. Saseen JJ, Grady SE, Hansen LB, et al. Future clinical pharmacy practitioners should be board-certified specialists. Pharmacotherapy. 2006;26:1816–25.
56. Heath and Human Services. The Affordable Care Act is working. http://www.hhs.gov/healthcare/facts-and-features/fact-sheets/aca-is-working/index.html#. Accessed 16 Dec 2015.
57. Bodenheimer TS, Smith MD. Primary care: proposed solutions to the physician shortage without training more physicians. Health Aff (Millwood). 2013;32:1881–6.
58. Smith M, Bates DW, Bodenheimer TS. Pharmacists belong in accountable care organizations and integrated care teams. Health Aff (Millwood). 2013;32:1963–70.
59. Centers for Medicare and Medicaid Services. http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ACO/index.html?redirect=/Aco. Accessed 16 Dec 2015.
60. Berenson RA, Hammons T, Gans DN, et al. A house is not a home: keeping patients at the center of practice redesign. Health Aff (Millwood). 2008;27:1219–30.
61. Rosenthal TC. Advancing medical homes: evidence-based literature review to inform health policy. http://www.ahec.buffalo.edu. Accessed 22 Jan 2016.
62. Kellerman R, Kirk L. Principles of the patient-centered medical home. Am Fam Physician. 2007;76:774–5.
63. Rosenthal TC. The medical home: growing evidence to support a new approach to primary care. J Am Board Fam Med. 2008;21:427–40.
64. National Committee for Quality Assurance. Patient centered medical home (PCMH 2014) standards. http://www.ncqa.org/Programs/Recognition/RelevanttoAllRecognition/RecognitionTraining/PCMH2014Standards.aspx. Accessed 1 Dec 2015.
65. Grumbach K, Bodenheimer T. Can health care teams improve primary care practice? JAMA. 2004;291:1246–51.
66. Shaw KM, Handler J, Wall HK, Kanter MH. Improving blood pressure control in a large multiethnic California population through changes in health care delivery, 2004–2012. Prev Chronic Dis. 2014;11:E191.
67. Reid RJ, Coleman K, Johnson EA, et al. The group health medical home at year two: cost savings, higher patient satisfaction, and less burnout for providers. Health Aff (Millwood). 2010;29:835–43.
68. Reid RJ, Fishman PA, Yu O, et al. Patient-centered medical home demonstration: a prospective, quasi-experimental, before and after evaluation. Am J Manag Care. 2009;15:e71–87.
69. Merenich JA, Olson KL, Delate T, Rasmussen J, Helling DK, Ward DG. Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease. Pharmacotherapy. 2007;27:1370–8.
70. Smith M, Bates DW, Bodenheimer T, Cleary PD. Why pharmacists belong in the medical home. Health Aff (Millwood). 2010;29:906–13.
71. Board of Pharmaceutical Specialties. 2014 annual report. http://board-of-pharmacy-specialties.epaperflip.com/v/2014-BPS-Annual-Report/#?page=8. Accessed 16 Dec 2015.